Nasdaq Imrx News Today

Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […]

Immuneering Co. (NASDAQ:IMRX – Get Free Report) insider Harold Eugene Brakewood bought 3,900 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average cost of $2.57 per share, for a total transaction of $10,023.00. Following the completion of the purchase, the insider now directly owns […]

Tucker Asset Management LLC bought a new stake in Immuneering Co. (NASDAQ:IMRX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,036 shares of the company’s stock, valued at approximately $112,000. A number of other institutional investors also […]

Immuneering Co. (NASDAQ:IMRX – Get Free Report)’s share price rose 18% during trading on Tuesday . The stock traded as high as $7.21 and last traded at $7.03. Approximately 54,309 shares changed hands during trading, a decline of 24% from the average daily volume of 71,238 shares. The stock had previously closed at $5.96. Analyst […]

Immuneering (NASDAQ:IMRX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a report released on Tuesday, Benzinga reports. They presently have a $25.00 price objective on the stock. Oppenheimer’s price target indicates a potential upside of 150.00% from the stock’s previous close. Several other brokerages have also […]

Morgan Stanley reaffirmed their equal weight rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a research report released on Friday morning, Benzinga reports. Morgan Stanley currently has a $14.00 target price on the stock. A number of other equities analysts have also weighed in on IMRX. Chardan Capital lifted their price objective on […]

Morgan Stanley reissued their equal weight rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a research note released on Friday, Benzinga reports. Morgan Stanley currently has a $14.00 price target on the stock. Other equities research analysts have also recently issued reports about the company. Chardan Capital lifted their target price on Immuneering […]

Immuneering Co. (NASDAQ:IMRX – Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 2,670,000 shares, a growth of 35.5% from the June 15th total of 1,970,000 shares. Based on an average daily volume of 122,800 shares, the […]

Immuneering Co. (NASDAQ:IMRX – Get Free Report)’s stock price dropped 2.3% during mid-day trading on Tuesday . The company traded as low as $9.76 and last traded at $9.92. Approximately 81,320 shares traded hands during mid-day trading, a decline of 3% from the average daily volume of 83,814 shares. The stock had previously closed at […]

Shares of Immuneering Co. (NASDAQ:IMRX – Get Rating) dropped 2.4% on Wednesday . The stock traded as low as $9.29 and last traded at $9.32. Approximately 82,591 shares were traded during trading, an increase of 38% from the average daily volume of 59,757 shares. The stock had previously closed at $9.55. Analyst Upgrades and Downgrades […]